: A favorite for its oncology pipeline, specifically the upcoming growth driver zanzalintinib for colorectal and kidney cancers.
These stocks are frequently highlighted by analysts for their high 2026 performance potential. best biotech stocks to buy now
These companies offer a blend of proven commercial success and high-upside catalysts. : A favorite for its oncology pipeline, specifically